The benefits of continuous ultrafiltration in pediatric cardiac surgery
Authors:
- Turkan TanselTTTurkan Tansel
- Murat BasaranMBMurat Basaran
- Eylul KafalıEKEylul Kafalı
- Murat UgurlucanMUMurat Ugurlucan
- Omer Ali SayınOSOmer Ali Sayın
- Ufuk AlpagutUAUfuk Alpagut
- Enver DayıogluEDEnver Dayıoglu
- Ertan OnursalEOErtan Onursal
- 1 January 2004
- journal article
- clinical trial
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 38 (5) , 307-311
Abstract
Systemic inflammatory response and capillary leak syndrome, caused by extracorporeal circulation, have negative effects on the function of vital organs during the postoperative period. Modified ultrafiltration (MUF) has been developed as an alternative method to reduce the detrimental effects of cardiopulmonary bypass. The aim of this prospective, randomized study is to analyze the effects of MUF in a pediatric population undergoing congenital cardiac surgery. Twenty-seven patients who underwent open-heart surgery at our institution were included in this prospective study. They were randomized into two groups as follows: Group I (n=14) of conventional ultrafiltration during bypass and Group II (n=13) receiving both conventional and modified ultrafiltration during and after the cessation of the bypass, respectively. The amount of prime volume, postoperative chest drain loss, transfusion requirements, hemodynamical parameters, duration of mechanical ventilatory support, and length of intensive care unit stay were compared between the two groups. During the postoperative period, the concentrations of hematological, biochemical and inflammatory parameters were also compared by analyzing the blood samples obtained at various time points. MUF resulted in a significant increase in hemoglobin, hematocrit and platelet levels, and significantly reduced the amount of chest tube output and transfused blood and blood products. MUF also shortened the duration of postoperative mechanical ventilatory support, length of the intensive care unit stay and improved postoperative hemodynamical parameters. During the early postoperative hours, IL-8 is significantly reduced in patients undergoing MUF, however, the concentrations of IL-8 were similar in both groups at the end of 24 h. MUF decreases the duration of mechanical ventilatory support, the length of intensive care unit stay, the need for blood transfusion and improves postoperative hemodynamics. It is associated with increased levels of hemoglobin, hematocrit and platelets. We can conclude that MUF attenuates the inflammatory response by decreasing the levels of inflammatory mediators.Keywords
This publication has 9 references indexed in Scilit:
- Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adultsEuropean Journal of Cardio-Thoracic Surgery, 2000
- Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypassThe Annals of Thoracic Surgery, 1999
- Dilutional And Modified Ultrafiltration Reduces Pulmonary Hypertension After Operations For Congenital Heart Disease: A Prospective Randomized StudyThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Modified Ultrafiltration Improves Left Ventricular Systolic Function In Infants After Cardiopulmonary BypassThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Modified Ultrafiltration Attenuates Dilutional Coagulopathy in Pediatric Open Heart OperationsThe Annals of Thoracic Surgery, 1997
- Modified ultrafiltration after cardiopulmonary bypass in pediatric cardiac surgeryThe Annals of Thoracic Surgery, 1997
- Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operationsThe Annals of Thoracic Surgery, 1996
- EFFICACY OF CONVECTIVE REMOVAL OF PLASMA MEDIATORS OF ENDOTOXIC SHOCK BY CONTINUOUS VENO-VENOUS HEMOFILTRATIONShock, 1996
- Abstracts of the XVII annual sessions of the North American section of the international society for heart research: Perdido Beach Resort, Orange Beach, Alabama, USA 21–25 May 1995Journal of Molecular and Cellular Cardiology, 1995